Industry: Pharmaceuticals, Biotechnology
Athenagen, Inc., located in South San Francisco, is engaged in the discovery and development of small-molecule drugs to treat neurovascular disease indications, such as Alzheimer’s disease, AMD and cognitive disorders. The company has two fundamental technology platforms: (i) beta-secretase inhibitors for the treatment of Alzheimer’s disease; and (ii) nACh receptor agonists and antagonists for the treatment of angiogenesis mediated diseases and cognitive ( www.athenagen.com )
Athenagen , Inc.
280 Utah Avenue Suite 275
South San Francisco, California 94080
USA
Tel: (650) 869-7600
Fax: (650) 869-7626